Jacob T. Brown, PharmD, MS

Dr. Brown completed his undergrad coursework and Doctor of Pharmacy at Creighton University. Upon graduation, he completed a Post-graduate Year 1 Pharmacy Residency at Children's Mercy Kansas City, followed by a T32 funded fellowship in Pediatric Clinical Pharmacology. During his fellowship he also completed a Master of Science in Clinical Research through the University of Kansas School of Medicine. Dr. Brown started as an assistant professor with the University of Minnesota College of Pharmacy, Duluth, in the fall of 2014.

Dr. Brown's expertise lies primarily within pediatric pharmacotherapy, pharmacogenetics, pharmacogenomics, and pharmacokinetics.

• American Society of Clinical Pharmacology and Therapeutics
• Pediatric Pharmacy Advocacy Group

Pediatrics, pharmacogenetics, pharmacogenomics, psychopharmacology, pharmacokinetics

Essentia Health Foundation

Brown JT, Gregornik D, Kennedy MJ. Pediatric pharmacy advocacy group position statement on pharmacogenomics in pediatrics. J Pediatr Pharmacol Ther. 2018 [Accepted].

Olander M, Waring S, Stenehjem DD, Taran A, Ranelli PL, Brown JT. Primary care clinicians' attitudes and knowledge of pharmacogenetics in a large, multi-state, healthcare system. Innovations in Pharmacy. [Accepted]

Frew JA, Brown JT, Fitzsimmons PN, Hoffman AD, Sadilek M, Grue CE, Nichols JW. Toxicokinetics of the neonicotinoid insecticide imidacloprid in rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol. [Accepted]

Glesener D, Anderson G, Li X, Brown JT, Amell J, Regal R, Ferguson D. Prescribing patterns of psychotropic medications for American Indian children in foster care. J Child and Adolesc Psychopharm. [Accepted]

Eum S, Schneiderhan ME, Brown JT, Lee AM, Bishop JR. Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: A case report. BMC Psychiatry 2017 Jul 3;17(1):238. doi: 10.1186/s12888-017-1396-x.